tiprankstipranks
Intra-Cellular Therapies (ITCI)
NASDAQ:ITCI

Intra-Cellular Therapies (ITCI) Similar Stocks

Compare
918 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Intra-Cellular Therapies
$128.60
$13.67B
75.49%
5 Buy
9 Hold
0 Sell
Moderate Buy
ACADIA Pharmaceuticals
$19.95
$3.38B
26.27
-19.72%
5 Buy
5 Hold
0 Sell
Moderate Buy
Biogen
$140.64
$20.07B
12.26
-36.79%
12 Buy
13 Hold
0 Sell
Moderate Buy
Neurocrine
$116.11
$11.36B
34.72
-7.62%
17 Buy
5 Hold
0 Sell
Strong Buy
Vertex Pharmaceuticals
$484.24
$118.67B
15.40%
14 Buy
12 Hold
1 Sell
Moderate Buy
SAGE Therapeutics
$7.31
$439.59M
-67.15%
2 Buy
13 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
ITCI
Intra-Cellular Therapies
128.60
56.67
78.78%
ACAD
ACADIA Pharmaceuticals
19.95
-4.90
-19.72%
BIIB
Biogen
140.64
-81.84
-36.79%
NBIX
Neurocrine
120.69
-12.68
-9.51%
VRTX
Vertex Pharmaceuticals
484.24
57.46
13.46%
SAGE
SAGE Therapeutics
7.31
-14.94
-67.15%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis